SSX2 and synovial sarcoma: The application of cutting-edge next-generation immunohistochemistry to the SS18-SSX chimeric protein (E9X9V) and the C-terminus of SSX (E5A2C) for the diagnosis of synovial sarcoma demonstrated excellent sensitivity and specificity [50].